Addex Therapeutics
Manufacturing · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Chemin Des Aulx 12, Plan-les-Ouates, Gen...Phone Number
+41 228841555Website
www.addexpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Addex Therapeutics
Addex Therapeutics is a clinical-stage pharmaceutical company specializing in the development and commercialization of allosteric modulators, a novel class of orally available small molecule drugs aimed at treating neurological disorders. Their pipeline includes candidates for conditions such as post-stroke recovery, substance use disorder, and chronic cough. The company collaborates with various partners to advance its research and development efforts. Addex Therapeutics targets healthcare providers and patients affected by neurological conditions.Explore more
Addex Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Addex Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Addex Therapeutics is spiking on competitors!
Click to see if Addex Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Addex Therapeutics launches new products
Addex Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Addex Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Addex Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Addex Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Addex Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Addex Therapeutics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Addex Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Addex Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Addex Therapeutics.
Addex Therapeutics financials insights
Gather financial insights about Addex Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2004
Series B
$55M
2021
Series C
$32M
Addex Therapeutics Tech Stack
A closer look at the technologies used by Addex Therapeutics
Most Recent Scoops
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Funding
Funding
Addex Therapeutics News & Media
Addex's Dipraglurant Restores Synaptic Plasticity in Models of Dystonia
Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that dipraglurant was able to rescue long-term impairment of synaptic plasticity in two well validated models of dystonia. The data were published in the journal, Neuropharmacology, under the title “Rescue of striatal long-term depression by chronic mGlu5 receptor negative allosteric modulation in distinct dystoni... ReadAddex Increases Issued Share Capital to Create Treasury Shares
Geneva, Switzerland, April 26, 2021 - Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it has increased its share capital from 39,748,635 to 49,272,952 through the issue of 9,524,317 new registered shares at a nominal value of CHF1 each to Addex Pharma S.A, its 100% wholly-owned subsidiary. The new shares, issued from the Company’s authorized capital, are listed
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Addex Therapeutics
Sign Up For FreeTo access detailed company insights
Addex Therapeutics is a clinical-stage pharmaceutical company specializing in the development and commercialization of allosteric modulators, a novel class of orally available small molecule drugs aimed at treating neurological disorders. Their pipeline includes candidates for conditions such as post-stroke recovery, substance use disorder, and chr... Read More
